Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

The Lancet

Volumn 371, Issue 9612, 2008, Pages 569-578

  Renehan, Andrew G ^a   Tyson, Margaret ^a   Egger, Matthias ^b,c   Heller, Richard F ^a   Zwahlen, Marcel ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; COLON CANCER; ELECTRONICS; EMBASE; ESOPHAGEAL ADENOCARCINOMA; ETHNICITY; GALLBLADDER CANCER; HUMAN; KIDNEY CANCER; LEUKEMIA; MEDLINE; MELANOMA; META ANALYSIS; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PANCREAS CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THYROID CANCER;

EID: 38949108241     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60269-X     Document Type: Article

References (75)

1. IARC. Weight control and physical activity. In: Vainio H., and Bianchini F. (Eds) (2002), International Agency for Research in Cancer Press, Lyon, France
2. WCRF. World Cancer Research Fund. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. 2nd edn. (2007), American Institute for Cancer Research, Washington, USA
3. Bergström A., Hsieh C., Lindblad P., Lu C., Cook N., and Wolk A. Obesity and renal cell cancer - a quantitative review. Br J Cancer 85 (2001) 984-990
4. Bergstrom A., Pisani P., Tenet V., Wolk A., and Adami H. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91 (2001) 421-430
5. de Gonzalez A.B., Sweetland S., and Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89 (2003) 519-523
6. Dal Maso L., La Vecchia C., Franceschi S., et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 11 (2000) 137-144
7. Kubo A., and Corley D. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 872-878
8. Larsson S., Orsini N., and Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 120 (2007) 1993-1998
9. Larsson S., and Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 96 (2007) 1457-1461
10. Larsson S., and Wolk A. Obesity and risk of non-Hodgkin's lymphoma: A meta-analysis. Int J Cancer 122 (2007) 1564-1570
11. Larsson S., and Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86 (2007) 556-565
12. Larsson S., and Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 97 (2007) 1005-1008
13. Larsson S., and Wolk A. Body mass index and risk of multiple myeloma: A meta-analysis. Int J Cancer 121 (2007) 2512-2516
14. Larsson S., and Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer (2007). published online Nov 2007. DOI: 10.1002/ijc.23176
15. MacInnis R., and English D. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17 (2006) 989-1003
16. Olsen C., Green A., Whiteman D., Sadeghi S., Kolahdooz F., and Webb P. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43 (2007) 690-709
17. Purdie D., Bain C., Webb P., Whiteman D., Pirozzo S., and Green A. Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 12 (2001) 855-863
18. Ursin G., Longnecker M., Haile R., and Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6 (1995) 137-141
19. van den Brandt P., Spiegelman D., Yaun S., et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152 (2000) 514-527
20. Reeves G., Pirie K., Beral V., Green J., Spencer E., and Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007). published online Nov 2007. DOI: 10.1136/bmj.39367.495995.AE
21. Iwasaki M., Otani T., Inoue M., Sasazuki S., and Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 17 (2007) 304-312
22. Kuriyama S., Tsubono Y., Hozawa A., et al. Obesity and risk of cancer in Japan. Int J Cancer 113 (2005) 148-157
23. Oh S., Yoon Y., and Shin S. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23 (2005) 4742-4754
24. Bianchini F., Kaaks R., and Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 3 (2002) 565-574
25. Calle E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004) 579-591
26. Kaaks R., Lukanova A., and Kurzer M. Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol Biomarkers Prev 11 (2002) 1531-1543
27. Orsini N., Bellocco R., and Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 6 (2006) 40-57
28. Haftenberger M., Lahmann P., Panico S., et al. Overweight, obesity and fat distribution in 50 to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5 (2002) 1147-1162
29. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
30. Higgins J., and Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
31. Thompson S., and Higgins J. How should meta-regression analyses be undertaken and interpreted?. Stat Med 21 (2002) 1559-1573
32. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull 47 (1999) 15-17
33. Egger M., Smith G.D., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
34. Li H., Gao Y., Li Q., and Liu D. [Anthropometry and female breast cancer: a prospective cohort study in urban Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi 27 (2006) 488-493
35. Nothlings U., Wilkens L., Murphy S., Hankin J., Henderson B., and Kolonel L. Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control 18 (2007) 165-175
36. Setiawan V., Pike M., Kolonel L., Nomura A., Goodman M., and Henderson B. Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol 165 (2007) 262-270
37. Setiawan V., Stram D., Nomura A., Kolonel L., and Henderson B. Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol 166 (2007) 932-940
38. Friedman G., and Herrinton L. Obesity and multiple myeloma. Cancer Causes Control 5 (1994) 479-483
39. Palmer J., Adams-Campbell L., Boggs D., Wise L., and Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 16 (2007) 1795-1802
40. Canoy D., Wareham N., Luben R., et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 13 (2005) 1466-1475
41. Kanashiki M., Sairenchi T., Saito Y., Ishikawa H., Satoh H., and Sekizawa K. Body mass index and lung cancer: a case-control study of subjects participating in a mass-screening program. Chest 128 (2005) 1490-1496
42. Kark J., Yaari S., Rasooly I., and Goldbourt U. Are lean smokers at increased risk of lung cancer? The Israel Civil Servant Cancer Study. Arch Intern Med 155 (1995) 2409-2416
43. Olson J., Yang P., Schmitz K., Vierkant R., Cerhan J., and Sellers T. Differential association of body mass index and fat distribution with three major histologic types of lung cancer: evidence from a cohort of older women. Am J Epidemiol 156 (2002) 606-615
44. Samanic C., Chow W., Gridley G., Jarvholm B., and Fraumeni Jr. J. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17 (2006) 901-909
45. Bjorge T., Tretli S., and Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160 (2004) 1168-1176
46. Engeland A., Tretli S., Austad G., and Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control 16 (2005) 987-996
47. Egger M., Schneider M., and Smith G.D. Spurious precision? Meta-analysis of observational studies. BMJ 316 (1998) 140-144
48. Schlesselman J. Case-control studies. Design, conduct, analysis (1982), Oxford University Press, New York, USA
49. Spencer E., Appleby P., Davey G., and Key T. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 5 (2002) 561-565
50. Kuczmarski M., Kuczmarski R., and Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Diet Assoc 101 (2001) 28-36
51. IARC. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2004), International Agency for Research on Cancer, Lyon, France
52. Lahmann P., Hoffmann K., Allen N., et al. Body size and breast cancer risk: Findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 111 (2004) 762-771
53. Mellemkjaer L., Bigaard J., Tjonneland A., et al. Body composition and breast cancer in postmenopausal women: a Danish prospective cohort study. Obesity (Silver Spring) 14 (2006) 1854-1862
54. Boyd N., Martin L., Sun L., et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15 (2006) 2086-2092
55. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
56. Connolly B., Barnett C., Vogt K., Li T., Stone J., and Boyd N. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44 (2003) 127-138
57. Harvie M., Hooper L., and Howell A. Central obesity and breast cancer risk: a systematic review. Obes Rev 4 (2003) 157-173
58. Hampel H., Abraham N., and El-Serag H. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143 (2005) 199-211
59. Carmichael A. Obesity and prognosis of breast cancer. Obes Rev 7 (2006) 333-340
60. Dignam J., Polite B., Yothers G., et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98 (2006) 1647-1654
61. Haydon A., Macinnis R., English D., Morris H., and Giles G. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Gut 55 (2006) 689-694
62. von Gruenigen V., Tian C., Frasure H., Waggoner S., Keys H., and Barakat R. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study. Cancer 107 (2006) 2786-2791
63. Kjaerbye-Thygesen A., Frederiksen K., Hogdall E., et al. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15 (2006) 798-803
64. Gong Z., Agalliu I., Lin D., Stanford J., and Kristal A. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 109 (2007) 1192-1202
65. Awakura Y., Nakamura E., Ito N., et al. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. Urology 70 (2007) 50-54
66. Renehan A., Frystyk J., and Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17 (2006) 328-336
67. Renehan A., Zwahlen M., Minder C., O'Dwyer S., Shalet S., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
68. Juul A., Bang P., Hertel N., et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78 (1994) 744-752
69. Derby C., Zilber S., Brambilla D., Morales K., and McKinlay J. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65 (2006) 125-131
70. Key T., Appleby P., Reeves G., et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95 (2003) 1218-1226
71. Rose D., Komninou D., and Stephenson G. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5 (2004) 153-165
72. Gago-Dominguez M., Castelao J., Yuan J., Ross R., and Yu M. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 13 (2002) 287-293
73. Ogden C., Carroll M., Curtin L., McDowell M., Tabak C., and Flegal K. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
74. Zaninotto P., Wardle H., Stamatakis E., Mindell J., and Head J. Forecasting Obesity to 2010 (2006), National Centre for Social Research, Department of Health, London, UK. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_4138630 (accessed Oct 4, 2007).
75. Ben-Shlomo Y., and Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 31 (2002) 285-293